Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma
Clinical trial NCT00810576 · TERMINATED
Trial details
- NCT number
- NCT00810576
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2010-04-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.